Select Language

CD99

CD99 Overview

English Name	CD99 antigen	Approved Drugs	0
Drugs in Clinical Trials	1	Target Synonym	12E7，E2 antigen，Protein MIC2，T-cell surface glycoprotein E2
Highest Development Stage	Phase 2 Clinical

English Name	CD99 antigen
Target Synonym	12E7，E2 antigen，Protein MIC2，T-cell surface glycoprotein E2
Approved Drugs	0
Drugs in Clinical Trials	1
Highest Development Stage	Phase 2 Clinical

CD99 Product List

Product Category
Protein (3)Antibody (1)
Product Status
Launched (4)
Species
Human (3)Rabbit (1)
Tag
His Tag (1)His Tag & Avi Tag (1)- (1)Llama IgG Fc Tag (1)
Conjugate
Unconjugated (3)Biotin-labeled (1)

Cat. No.	Species	Host	Product Description
HOT CD9-H5221	Human	HEK293	Human CD99 / MIC2 Protein, His Tag
HOT CD9-H82E7	Human	HEK293	Biotinylated Human CD99 / MIC2 Protein, His,Avitag™
CD9-H5254	Human	HEK293	Human CD99 / MIC2 Protein, Llama IgG2b Fc Tag, low Endotoxin (MALS verified)
HGS-S263	Rabbit	-	Recombinant Monoclonal Anti-CD99 Antibody, Rabbit (4F5)

Total: 4

CD99 Background

CD99 antigen is also known as MIC2, single-chain type-1 glycoprotein, HBA71, MIC2X, MIC2Y, MSK5X, 12E7, which belongs to the CD99 family. CD99 / MIC2 is expressed on all leukocytes but highest on thymocytes. Involved in T-cell adhesion processes and in spontaneous rosette formation with erythrocytes. CD99 / MIC2 plays a role in a late step of leukocyte extravasation helping leukocytes to overcome the endothelial basement membrane. CD99 acts at the same site as, but independently of PECAM1. There is also experimental evidence that it binds to cyclophilin A.